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A commentary on
Do health care workforce, population, and service provision significantly contribute to the total
health expenditure? An econometric analysis of Serbia
by Santric-Milicevic, M., Vasic, V., and Terzic-Supic, Z. (2016). Hum. Resour. Health 14:50. doi: 10.
1186/s12960-016-0146-3
With interest we have been reading the recent article entitled: “Do health care workforce,
population, and service provision significantly contribute to the total health expenditure? An
econometric analysis of Serbia” (Santric-Milicevic et al., 2016). Authors provided a decent piece
of econometric modeling analysis. Here they evaluated on a supply side a considerable burden
imposed by the pool of professional health workforce employees. Authors have pointed out that
“the growth of the health workforce number in the previous year has strongly contributed to the
growth of total health expenditure in Serbia from 2003 to 2011.” Time series modeling approach
adds to the scarce body of evidence on health expenditure determinants in post-socialist Eastern
European societies.
However, there are few significant gaps in the article deserving to build them upwith the omitted
evidence. In the explanatory background section a lot has been said about the structural reforms of
the national health system. These reforms were to a large extent led by the external consultancies
provided by theWorld Bank through the Health Project Serbia1 and Second Serbia Health Project2
whose recommendations were adopted by frequently changing national governments since the
early 2000s. These changes took place for well over a decade and a half. Some of them, like the
attempt to establish the national health technology assessment (HTA) agency, did that with a very
limited success (Jakovljevic et al., 2011). Understanding of these background processes is necessary
to catch a glimpse of the big picture in the Balkan health systems (Bredenkamp et al., 2011). Actual
lack of confidence of health care professionals in many of these reform initiatives has been shown
in large scale national surveys of clinical physicians (Jakovljevic et al., 2016a). Others point out to
the significant growth of inequalities in terms of medical care access and affordability among the
ordinary citizens in recent years (Radevic et al., 2016).
1Health Project (Serbia). http://www.worldbank.org/projects/P077675/health-project-serbia?lang=en. Accessed: 01 October
2016.
2Second Serbia Health Project. http://www.worldbank.org/projects/P129539/second-serbia-health-project?lang=en.
Accessed: 01 October 2016.
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In the section entitled “Drivers of health expenditure in the
Republic of Serbia” little has been said about the microeconomic
drivers of local medical spending. Mostly top-down national
health reports were cited in this chapter. However, there is
a strong body of quantified, bottom-up assessments on real-
world costs of care in Serbian health system. Over the past 15
years academic health economists have identified core drivers of
high costs of inpatient and outpatient medical care. Innovative
pharmaceuticals imaging diagnostics, interventional radiology
procedures, dental care and radiotherapy in oncology are among
the highest impact ones (Jakovljevic et al., 2013, 2014, 2015a;
Rankovic et al., 2013; Rancˇic´ et al., 2015). A set of regional
cost of illness analysis have been conducted as well pointing
out that non-communicable prosperity diseases sharing the
highest budget impact were high risk pregnancies, diabetes,
depression, alcohol addiction, HIV/AIDS, COPD and cancer
(Jakovljevic et al., 2008; Biorac et al., 2009; Jovanovic and
Jakovljevic, 2011; Dagovic et al., 2014; Cupurdija et al., 2015;
Jakovljevic´ et al., 2015; Arnlöv, 2016). Good example as well is
the structural trend analysis on long term health expenditure
evolution in Serbia published few years ago (Jakovljevic, 2014).
Since the focus of the source article is health spending we
should emphasize the evolving role of evidence based resource
allocation in all of former Yugoslavia’s republics (Jakovljevic,
2013). When explaining the growing availability of professional
staff in Serbia, authors properly notice: “Throughout that period,
the accessibility of physicians, nurses, and midwives per 10 000
population has increased by 14 % but with significant inequity
across districts.” However, they miss to mention the scale of
geographical inequality in density of staff distribution. Most of
this pool of physicians, nursing and associated medical staff is
concentrated in four largest cities with heavily neglected rural
periphery. Heavy migration of skilled labor force toward rich
urban cores happens due to higher living standards and stronger
employment prospects (Stilwell et al., 2004). Some relief could
be found in a skillful financing and provision of primary care
services throughout the country (Konstantinovic´ et al., 2012).
This exceptional centralization of health workforce capacities in
capital cities is not unique to Serbia. It presents a landmark of
many Eastern European health systems (Simai, 2006). This is
even more prominent in dental workforce and pharmaceutical
spending evolution going in different directions in Eastern
and Western Europe alongside former Cold War borderlines
(Jakovljevic et al., 2016b,c).
In conclusion, authors noticed the role of the growing
size of an aging population coupled with strong emigration
net rates (Santric-Milicevic et al., 2014). Probably the most
typical challenge of rising portion of elderly to the long term
sustainability of health care financing could be found in the
eldest of nations—Japanese one (Ogura and Jakovljevic, 2014).
Nevertheless we should not forget the broad perspective of the
population aging in Europe which might be bringing some
opportunities together with the difficulties (Jakovljevic, 2015a).
Keeping in mind Eastern European perspective, there has been
straight forward evidence on connection between the health
expenditure long term dynamics and the extension of human
longevity (Jakovljevic et al., 2015b). Other major drivers of
spending such as the chronic illnesses could be efficiently
tackled by more effective provision and financing of hospital
care (Mihailovic et al., 2016). Even more promising is the
investment into the preventive screenings and other primary
outpatient care and life style interventions as was the case
in nearby Hungary (Sándor et al., 2016). One of the cost-
effective strategies is improved quality of pharmacotherapy
nationwide in terms of better patient compliance (Gustafsson
et al., 2011). Another complimentary approach is dissemination
of good clinical practice guidelines controlling the rate of drug
adverse events in hospital and outpatient care (Godman et al.,
2013). Pharmaceuticals acquisition costs could be contained
by ongoing transformation of the local market targeted to
strengthen generic substitution of brand name drugs (Woerkom
et al., 2012; Howard et al., 2015). Authors are right in their
rather pessimistic opinion on prospects of national health
expenditure growth in Serbia up to 2020. But to have these
long term projections more reliable, due to their peculiarity, we
should look toward more similar health systems such as those
of the leading BRICS emerging markets (Jakovljevic, 2015b).
Many of these nations share the historical legacy of health
care establishments similar to that of Serbia to a large degree.
Getzen’s excess growth model in forecasting health expenditures
gives us hints of what is going on in these nations up to
2025 (Jakovljevic et al., 2016d). Since they have been burdened
with similar issues and constraints far earlier and too a far
larger extent, small post-socialist nations might be capable to
learn valuable lessons for their own future (Jakovljevic et al.,
2016e).
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